Treatment modalities and long-term outcomes of hepatic hemangioendothelioma in the United States C Kaltenmeier, S Stacchiotti, A Gronchi, G Sapisochin, H Liu, E Ashwat, ... HPB 24 (10), 1688-1696, 2022 | 7 | 2022 |
No survival benefit with suboptimal CA19-9 response: defining effective neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer H Liu, M D'Alesio, S AlMasri, A Hammad, A Desilva, S Lebowitz, C Rieser, ... HPB 25 (5), 521-532, 2023 | 5 | 2023 |
Validation of the liver transplant risk score in Europe E Ashwat, C Kaltenmeier, H Liu, D Reddy, A Thompson, S Dharmayan, ... British Journal of Surgery 110 (3), 302-305, 2023 | 5 | 2023 |
Current status of living donor liver transplantation: impact, advantages, and challenges H Liu, E Ashwat, A Humar Current Gastroenterology Reports 25 (10), 225-231, 2023 | 4 | 2023 |
Outcomes of Radial Artery Versus Saphenous Vein as A Second Conduit After Coronary Artery Bypass Grafting E Ashwat, JA Brown, S Yousef, D Ahmad, Y Wang, FW Thoma, ... The American Journal of Cardiology 214, 33-39, 2024 | 1 | 2024 |
Function and longevity of renal grafts from high‐KDPI donors M Molinari, C Kaltenmeier, H Liu, E Ashwat, D Jorgensen, C Puttarajappa, ... Clinical Transplantation 36 (9), e14759, 2022 | 1 | 2022 |
748: DEFINING EFFECTIVE NEOADJUVANT CHEMOTHERAPY (NAC) IN PDAC, IMPLICATIONS FROM SURVIVAL AND PATTERN OF FAILURE IN PATIENTS WHO RECEIVED NAC H Liu, M D'Alesio, S AlMasri, AY Hammad, A deSilva, C Rieser, E Ashwat, ... Gastroenterology 162 (7), S-1331-S-1332, 2022 | 1 | 2022 |
Su1376: Higher hepatocellular carcinoma tumor burden score is associated with greater liver transplant survival benefit H Liu, W Zhang, M Di, H Lee, R Cruz, X Wang, C Kaltenmeier, ... Gastroenterology 162 (7), S-1198, 2022 | 1 | 2022 |
Acute Aortic Dissection After Transcatheter Aortic Valve Replacement E Ashwat, D Ahmad, MP Sá, A Jackson, JA Brown, D Serna-Gallegos, ... The American Journal of Cardiology 222, 108-112, 2024 | | 2024 |
Donor-recipient race-ethnicity concordance and patient survival after liver transplantation M Laffey, E Ashwat, H Lui, X Zhang, C Kaltenmeier, G Packiaraj, A Crane, ... HPB 26 (6), 772-781, 2024 | | 2024 |
Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility S Leonard-Murali, C Bhaskarla, GS Yadav, SK Maurya, CR Galiveti, ... Nature Communications 15 (1), 2863, 2024 | | 2024 |
Radial artery vs right internal mammary artery as a second conduit during coronary artery bypass grafting E Ashwat, JA Brown, S Yousef, D Ahmad, Y Wang, FW Thoma, ... American Heart Journal 270, 44-54, 2024 | | 2024 |
Liver retransplants using living donors: An approach for management H Al Harakeh, C Hughes, A Tevar, V Gunabushanam, E Ashwat, H Liu, ... Liver Research 7 (3), 252-255, 2023 | | 2023 |
Author response to: Validation of the Liver Transplant Risk Score in Europe M Molinari, E Ashwat British Journal of Surgery 110 (2), 278-278, 2023 | | 2023 |
HIGHER HEPATOCELLULAR CARCINOMA TUMOR BURDEN SCORE IS ASSOCIATED WITH GREATER LIVER TRANSPLANT SURVIVAL BENEFIT H Liu, W Zhang, M Di, H Lee, R Cruz, X Wang, C Kaltenmeier, ... GASTROENTEROLOGY 162 (7), S1198-S1198, 2022 | | 2022 |
Defining Effective Neoadjuvant Chemotherapy (NAC) in PDAC, Implications from Survival and Pattern of Failure in Patients Who Received NAC H Liu, M D'Alesio, S Al Masri, AY Hammad, A De Silva, E Ashwat, ... ANNALS OF SURGICAL ONCOLOGY 29 (SUPPL 2), 386-386, 2022 | | 2022 |
Stratification of Perioperative Mortality and Long-Term Survival in Liver Transplant Recipients at Listing: Validity of The Liver Transplant Risk Score (LTRS) in a European Cohort E Ashwat, C Kaltenmeier, S Nadalin, O Ciccarelli, C Hughes, A Humar, ... HPB 24, S31, 2022 | | 2022 |
Neoadjuvant Chemotherapy Resulting in Suboptimal CA19-9 Response is Associated with No Survival Benefit Compared to Surgery First Approach in Resectable or Borderline … H Liu, M D'Alesio, S Al Masri, A Hammad, A Desilva, E Ashwat, ... HPB 24, S2-S3, 2022 | | 2022 |
The Persistent Survival Gap of African American Undergoing Liver Transplantation for Stage II Hepatocellular Carcinoma in The United States H Liu, C Kaltenmeier, E Ashwat, S Tohme, C Hughes, V Gunabushanam, ... HPB 24, S566-S567, 2022 | | 2022 |
The Effect of Donor-Recipient Race and Ethnicity Match on Liver Transplantation Outcome in The United States H Liu, C Kaltenmeier, R Cruz, A Thompson, D Reddy, M D'Alesio, ... HPB 24, S572, 2022 | | 2022 |